<?xml version="1.0" encoding="utf-8"?>
<uniprot xmlns="http://uniprot.org/uniprot" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://uniprot.org/uniprot http://www.uniprot.org/support/docs/uniprot.xsd">
<entry dataset="Swiss-Prot" created="2007-06-26" modified="2020-10-07" version="147">
<accession>Q96AD5</accession>
<accession>O60643</accession>
<accession>Q5EFF5</accession>
<accession>Q6XYE5</accession>
<accession>Q96ET6</accession>
<accession>Q9NQ61</accession>
<accession>Q9NQ62</accession>
<name>PLPL2_HUMAN</name>
<protein>
<recommendedName>
<fullName evidence="26">Patatin-like phospholipase domain-containing protein 2</fullName>
<ecNumber evidence="10">3.1.1.3</ecNumber>
</recommendedName>
<alternativeName>
<fullName evidence="24">Adipose triglyceride lipase</fullName>
</alternativeName>
<alternativeName>
<fullName>Calcium-independent phospholipase A2</fullName>
</alternativeName>
<alternativeName>
<fullName>Desnutrin</fullName>
</alternativeName>
<alternativeName>
<fullName>IPLA2-zeta</fullName>
</alternativeName>
<alternativeName>
<fullName>Pigment epithelium-derived factor</fullName>
</alternativeName>
<alternativeName>
<fullName evidence="25">TTS2.2</fullName>
</alternativeName>
<alternativeName>
<fullName>Transport-secretion protein 2</fullName>
<shortName>TTS2</shortName>
</alternativeName>
</protein>
<gene>
<name type="primary" evidence="30">PNPLA2</name>
<name type="synonym" evidence="24">ATGL</name>
<name type="ORF">FP17548</name>
</gene>
<organism>
<name type="scientific">Homo sapiens</name>
<name type="common">Human</name>
<dbReference type="NCBI Taxonomy" id="9606"/>
<lineage>
<taxon>Eukaryota</taxon>
<taxon>Metazoa</taxon>
<taxon>Chordata</taxon>
<taxon>Craniata</taxon>
<taxon>Vertebrata</taxon>
<taxon>Euteleostomi</taxon>
<taxon>Mammalia</taxon>
<taxon>Eutheria</taxon>
<taxon>Euarchontoglires</taxon>
<taxon>Primates</taxon>
<taxon>Haplorrhini</taxon>
<taxon>Catarrhini</taxon>
<taxon>Hominidae</taxon>
<taxon>Homo</taxon>
</lineage>
</organism>
<reference key="1">
<citation type="journal article" date="2004" name="Science" volume="306" first="1383" last="1386">
<title>Fat mobilization in adipose tissue is promoted by adipose triglyceride lipase.</title>
<authorList>
<person name="Zimmermann R."/>
<person name="Strauss J.G."/>
<person name="Haemmerle G."/>
<person name="Schoiswohl G."/>
<person name="Birner-Gruenberger R."/>
<person name="Riederer M."/>
<person name="Lass A."/>
<person name="Neuberger G."/>
<person name="Eisenhaber F."/>
<person name="Hermetter A."/>
<person name="Zechner R."/>
</authorList>
<dbReference type="PubMed" id="15550674"/>
<dbReference type="DOI" id="10.1126/science.1100747"/>
</citation>
<scope>NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1)</scope>
<scope>FUNCTION</scope>
<scope>TISSUE SPECIFICITY</scope>
<scope>CATALYTIC ACTIVITY</scope>
</reference>
<reference key="2">
<citation type="submission" date="2000-06" db="EMBL/GenBank/DDBJ databases">
<title>TTS-2, a novel protein implicated in vesicular transport of the cell surface receptor ICAM-3.</title>
<authorList>
<person name="Strahl T."/>
<person name="Shingler W.H."/>
<person name="Lammiman M."/>
<person name="Gregory C.D."/>
<person name="Leach L."/>
<person name="Matthias P."/>
<person name="Nielsen P.J."/>
<person name="Shaw P.E."/>
</authorList>
</citation>
<scope>NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1)</scope>
<scope>VARIANT PRO-481</scope>
</reference>
<reference key="3">
<citation type="journal article" date="2004" name="Proc. Natl. Acad. Sci. U.S.A." volume="101" first="15724" last="15729">
<title>Large-scale cDNA transfection screening for genes related to cancer development and progression.</title>
<authorList>
<person name="Wan D."/>
<person name="Gong Y."/>
<person name="Qin W."/>
<person name="Zhang P."/>
<person name="Li J."/>
<person name="Wei L."/>
<person name="Zhou X."/>
<person name="Li H."/>
<person name="Qiu X."/>
<person name="Zhong F."/>
<person name="He L."/>
<person name="Yu J."/>
<person name="Yao G."/>
<person name="Jiang H."/>
<person name="Qian L."/>
<person name="Yu Y."/>
<person name="Shu H."/>
<person name="Chen X."/>
<person name="Xu H."/>
<person name="Guo M."/>
<person name="Pan Z."/>
<person name="Chen Y."/>
<person name="Ge C."/>
<person name="Yang S."/>
<person name="Gu J."/>
</authorList>
<dbReference type="PubMed" id="15498874"/>
<dbReference type="DOI" id="10.1073/pnas.0404089101"/>
</citation>
<scope>NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 2)</scope>
</reference>
<reference key="4">
<citation type="journal article" date="2004" name="Genome Res." volume="14" first="2121" last="2127">
<title>The status, quality, and expansion of the NIH full-length cDNA project: the Mammalian Gene Collection (MGC).</title>
<authorList>
<consortium name="The MGC Project Team"/>
</authorList>
<dbReference type="PubMed" id="15489334"/>
<dbReference type="DOI" id="10.1101/gr.2596504"/>
</citation>
<scope>NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 1)</scope>
<scope>VARIANT PRO-481</scope>
<source>
<tissue>Brain</tissue>
<tissue>Eye</tissue>
</source>
</reference>
<reference key="5">
<citation type="submission" date="1998-03" db="EMBL/GenBank/DDBJ databases">
<authorList>
<person name="Yu W."/>
<person name="Gibbs R.A."/>
</authorList>
</citation>
<scope>NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] OF 94-504 (ISOFORM 1)</scope>
<source>
<tissue>Brain</tissue>
</source>
</reference>
<reference key="6">
<citation type="journal article" date="2004" name="J. Biol. Chem." volume="279" first="48968" last="48975">
<title>Identification, cloning, expression, and purification of three novel human calcium-independent phospholipase A2 family members possessing triacylglycerol lipase and acylglycerol transacylase activities.</title>
<authorList>
<person name="Jenkins C.M."/>
<person name="Mancuso D.J."/>
<person name="Yan W."/>
<person name="Sims H.F."/>
<person name="Gibson B."/>
<person name="Gross R.W."/>
</authorList>
<dbReference type="PubMed" id="15364929"/>
<dbReference type="DOI" id="10.1074/jbc.m407841200"/>
</citation>
<scope>FUNCTION</scope>
<scope>ACTIVITY REGULATION</scope>
<scope>CATALYTIC ACTIVITY</scope>
</reference>
<reference key="7">
<citation type="journal article" date="2005" name="Diabetes" volume="54" first="3190" last="3197">
<title>Adipocyte lipases and defect of lipolysis in human obesity.</title>
<authorList>
<person name="Langin D."/>
<person name="Dicker A."/>
<person name="Tavernier G."/>
<person name="Hoffstedt J."/>
<person name="Mairal A."/>
<person name="Ryden M."/>
<person name="Arner E."/>
<person name="Sicard A."/>
<person name="Jenkins C.M."/>
<person name="Viguerie N."/>
<person name="van Harmelen V."/>
<person name="Gross R.W."/>
<person name="Holm C."/>
<person name="Arner P."/>
</authorList>
<dbReference type="PubMed" id="16249444"/>
<dbReference type="DOI" id="10.2337/diabetes.54.11.3190"/>
</citation>
<scope>DEVELOPMENTAL STAGE</scope>
<scope>TISSUE SPECIFICITY</scope>
</reference>
<reference key="8">
<citation type="journal article" date="2005" name="J. Lipid Res." volume="46" first="2477" last="2487">
<title>Expression, regulation, and triglyceride hydrolase activity of Adiponutrin family members.</title>
<authorList>
<person name="Lake A.C."/>
<person name="Sun Y."/>
<person name="Li J.-L."/>
<person name="Kim J.E."/>
<person name="Johnson J.W."/>
<person name="Li D."/>
<person name="Revett T."/>
<person name="Shih H.H."/>
<person name="Liu W."/>
<person name="Paulsen J.E."/>
<person name="Gimeno R.E."/>
</authorList>
<dbReference type="PubMed" id="16150821"/>
<dbReference type="DOI" id="10.1194/jlr.m500290-jlr200"/>
</citation>
<scope>TISSUE SPECIFICITY</scope>
<scope>MUTAGENESIS OF SER-47</scope>
<scope>CATALYTIC ACTIVITY</scope>
</reference>
<reference key="9">
<citation type="journal article" date="2006" name="Am. J. Physiol." volume="291" first="E115" last="E127">
<title>The adipose tissue triglyceride lipase ATGL/PNPLA2 is downregulated by insulin and TNF-alpha in 3T3-L1 adipocytes and is a target for transactivation by PPARgamma.</title>
<authorList>
<person name="Kim J.Y."/>
<person name="Tillison K."/>
<person name="Lee J.-H."/>
<person name="Rearick D.A."/>
<person name="Smas C.M."/>
</authorList>
<dbReference type="PubMed" id="16705060"/>
<dbReference type="DOI" id="10.1152/ajpendo.00317.2005"/>
</citation>
<scope>DEVELOPMENTAL STAGE</scope>
</reference>
<reference key="10">
<citation type="journal article" date="2006" name="EMBO Rep." volume="7" first="106" last="113">
<title>ATGL has a key role in lipid droplet/adiposome degradation in mammalian cells.</title>
<authorList>
<person name="Smirnova E."/>
<person name="Goldberg E.B."/>
<person name="Makarova K.S."/>
<person name="Lin L."/>
<person name="Brown W.J."/>
<person name="Jackson C.L."/>
</authorList>
<dbReference type="PubMed" id="16239926"/>
<dbReference type="DOI" id="10.1038/sj.embor.7400559"/>
</citation>
<scope>FUNCTION</scope>
<scope>SUBCELLULAR LOCATION</scope>
<scope>MUTAGENESIS OF SER-47</scope>
</reference>
<reference key="11">
<citation type="journal article" date="2006" name="J. Biol. Chem." volume="281" first="38022" last="38037">
<title>Identification of a lipase-linked cell membrane receptor for pigment epithelium-derived factor.</title>
<authorList>
<person name="Notari L."/>
<person name="Baladron V."/>
<person name="Aroca-Aguilar J.D."/>
<person name="Balko N."/>
<person name="Heredia R."/>
<person name="Meyer C."/>
<person name="Notario P.M."/>
<person name="Saravanamuthu S."/>
<person name="Nueda M.-L."/>
<person name="Sanchez-Sanchez F."/>
<person name="Escribano J."/>
<person name="Laborda J."/>
<person name="Becerra S.P."/>
</authorList>
<dbReference type="PubMed" id="17032652"/>
<dbReference type="DOI" id="10.1074/jbc.m600353200"/>
</citation>
<scope>ACTIVITY REGULATION</scope>
<scope>BIOPHYSICOCHEMICAL PROPERTIES</scope>
<scope>INTERACTION WITH SERPINF1</scope>
<scope>SUBCELLULAR LOCATION</scope>
<scope>TISSUE SPECIFICITY</scope>
<scope>DEVELOPMENTAL STAGE</scope>
</reference>
<reference key="12">
<citation type="journal article" date="2007" name="Biochem. Biophys. Res. Commun." volume="360" first="501" last="506">
<title>A comparative study of human GS2, its paralogues, and its rat orthologue.</title>
<authorList>
<person name="Gao J.G."/>
<person name="Simon M."/>
</authorList>
<dbReference type="PubMed" id="17603008"/>
<dbReference type="DOI" id="10.1016/j.bbrc.2007.06.089"/>
</citation>
<scope>CATALYTIC ACTIVITY</scope>
<scope>FUNCTION</scope>
</reference>
<reference key="13">
<citation type="journal article" date="2008" name="Proc. Natl. Acad. Sci. U.S.A." volume="105" first="10762" last="10767">
<title>A quantitative atlas of mitotic phosphorylation.</title>
<authorList>
<person name="Dephoure N."/>
<person name="Zhou C."/>
<person name="Villen J."/>
<person name="Beausoleil S.A."/>
<person name="Bakalarski C.E."/>
<person name="Elledge S.J."/>
<person name="Gygi S.P."/>
</authorList>
<dbReference type="PubMed" id="18669648"/>
<dbReference type="DOI" id="10.1073/pnas.0805139105"/>
</citation>
<scope>IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS]</scope>
<source>
<tissue>Cervix carcinoma</tissue>
</source>
</reference>
<reference key="14">
<citation type="journal article" date="2011" name="Sci. Signal." volume="4" first="RS3" last="RS3">
<title>System-wide temporal characterization of the proteome and phosphoproteome of human embryonic stem cell differentiation.</title>
<authorList>
<person name="Rigbolt K.T."/>
<person name="Prokhorova T.A."/>
<person name="Akimov V."/>
<person name="Henningsen J."/>
<person name="Johansen P.T."/>
<person name="Kratchmarova I."/>
<person name="Kassem M."/>
<person name="Mann M."/>
<person name="Olsen J.V."/>
<person name="Blagoev B."/>
</authorList>
<dbReference type="PubMed" id="21406692"/>
<dbReference type="DOI" id="10.1126/scisignal.2001570"/>
</citation>
<scope>PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-428</scope>
<scope>IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS]</scope>
</reference>
<reference key="15">
<citation type="journal article" date="2012" name="Endocrinology" volume="153" first="4278" last="4289">
<title>Identification and functional characterization of protein kinase A phosphorylation sites in the major lipolytic protein, adipose triglyceride lipase.</title>
<authorList>
<person name="Pagnon J."/>
<person name="Matzaris M."/>
<person name="Stark R."/>
<person name="Meex R.C."/>
<person name="Macaulay S.L."/>
<person name="Brown W."/>
<person name="O'Brien P.E."/>
<person name="Tiganis T."/>
<person name="Watt M.J."/>
</authorList>
<dbReference type="PubMed" id="22733971"/>
<dbReference type="DOI" id="10.1210/en.2012-1127"/>
</citation>
<scope>PHOSPHORYLATION AT SER-404</scope>
</reference>
<reference key="16">
<citation type="journal article" date="2013" name="J. Proteome Res." volume="12" first="260" last="271">
<title>Toward a comprehensive characterization of a human cancer cell phosphoproteome.</title>
<authorList>
<person name="Zhou H."/>
<person name="Di Palma S."/>
<person name="Preisinger C."/>
<person name="Peng M."/>
<person name="Polat A.N."/>
<person name="Heck A.J."/>
<person name="Mohammed S."/>
</authorList>
<dbReference type="PubMed" id="23186163"/>
<dbReference type="DOI" id="10.1021/pr300630k"/>
</citation>
<scope>PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-404 AND SER-428</scope>
<scope>IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS]</scope>
<source>
<tissue>Cervix carcinoma</tissue>
<tissue>Erythroleukemia</tissue>
</source>
</reference>
<reference key="17">
<citation type="journal article" date="2013" name="Proc. Natl. Acad. Sci. U.S.A." volume="110" first="1345" last="1350">
<title>Spatial regulation of UBXD8 and p97/VCP controls ATGL-mediated lipid droplet turnover.</title>
<authorList>
<person name="Olzmann J.A."/>
<person name="Richter C.M."/>
<person name="Kopito R.R."/>
</authorList>
<dbReference type="PubMed" id="23297223"/>
<dbReference type="DOI" id="10.1073/pnas.1213738110"/>
</citation>
<scope>INTERACTION WITH FAF2</scope>
</reference>
<reference key="18">
<citation type="journal article" date="2014" name="J. Proteomics" volume="96" first="253" last="262">
<title>An enzyme assisted RP-RPLC approach for in-depth analysis of human liver phosphoproteome.</title>
<authorList>
<person name="Bian Y."/>
<person name="Song C."/>
<person name="Cheng K."/>
<person name="Dong M."/>
<person name="Wang F."/>
<person name="Huang J."/>
<person name="Sun D."/>
<person name="Wang L."/>
<person name="Ye M."/>
<person name="Zou H."/>
</authorList>
<dbReference type="PubMed" id="24275569"/>
<dbReference type="DOI" id="10.1016/j.jprot.2013.11.014"/>
</citation>
<scope>PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-428</scope>
<scope>IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS]</scope>
<source>
<tissue>Liver</tissue>
</source>
</reference>
<reference key="19">
<citation type="journal article" date="2015" name="Cell" volume="161" first="1619" last="1632">
<title>A single kinase generates the majority of the secreted phosphoproteome.</title>
<authorList>
<person name="Tagliabracci V.S."/>
<person name="Wiley S.E."/>
<person name="Guo X."/>
<person name="Kinch L.N."/>
<person name="Durrant E."/>
<person name="Wen J."/>
<person name="Xiao J."/>
<person name="Cui J."/>
<person name="Nguyen K.B."/>
<person name="Engel J.L."/>
<person name="Coon J.J."/>
<person name="Grishin N."/>
<person name="Pinna L.A."/>
<person name="Pagliarini D.J."/>
<person name="Dixon J.E."/>
</authorList>
<dbReference type="PubMed" id="26091039"/>
<dbReference type="DOI" id="10.1016/j.cell.2015.05.028"/>
</citation>
<scope>PHOSPHORYLATION AT SER-404</scope>
</reference>
<reference key="20">
<citation type="journal article" date="2006" name="Diabetes" volume="55" first="1270" last="1275">
<title>The ATGL gene is associated with free fatty acids, triglycerides, and type 2 diabetes.</title>
<authorList>
<person name="Schoenborn V."/>
<person name="Heid I.M."/>
<person name="Vollmert C."/>
<person name="Lingenhel A."/>
<person name="Adams T.D."/>
<person name="Hopkins P.N."/>
<person name="Illig T."/>
<person name="Zimmermann R."/>
<person name="Zechner R."/>
<person name="Hunt S.C."/>
<person name="Kronenberg F."/>
</authorList>
<dbReference type="PubMed" id="16644682"/>
<dbReference type="DOI" id="10.2337/db05-1498"/>
</citation>
<scope>VARIANTS PHE-219; LYS-252 AND PRO-481</scope>
<scope>POLYMORPHISM</scope>
<scope>ASSOCIATION WITH DIABETES MELLITUS TYPE 2</scope>
</reference>
<reference key="21">
<citation type="journal article" date="2007" name="Nat. Genet." volume="39" first="28" last="30">
<title>The gene encoding adipose triglyceride lipase (PNPLA2) is mutated in neutral lipid storage disease with myopathy.</title>
<authorList>
<person name="Fischer J."/>
<person name="Lefevre C."/>
<person name="Morava E."/>
<person name="Mussini J.-M."/>
<person name="Laforet P."/>
<person name="Negre-Salvayre A."/>
<person name="Lathrop M."/>
<person name="Salvayre R."/>
</authorList>
<dbReference type="PubMed" id="17187067"/>
<dbReference type="DOI" id="10.1038/ng1951"/>
</citation>
<scope>VARIANT NLSDM LEU-195</scope>
</reference>
<comment type="function">
<text evidence="5 8 10 11 12 18">Catalyzes the initial step in triglyceride hydrolysis in adipocyte and non-adipocyte lipid droplets (PubMed:15550674, PubMed:15364929, PubMed:16150821). Exhibits a strong preference for the hydrolysis of long-chain fatty acid esters at the sn-2 position of the glycerol backbone (By similarity). Also has acylglycerol transacylase activity. Acts coordinately with LIPE/HLS and DGAT2 within the lipolytic cascade (By similarity). Transfers fatty acid from triglyceride to retinol, hydrolyzes retinylesters, and generates 1,3-diacylglycerol from triglycerides (PubMed:17603008). Regulates adiposome size and may be involved in the degradation of adiposomes (PubMed:16239926). May play an important role in energy homeostasis. May play a role in the response of the organism to starvation, enhancing hydrolysis of triglycerides and providing free fatty acids to other tissues to be oxidized in situations of energy depletion (By similarity).</text>
</comment>
<comment type="catalytic activity">
<reaction evidence="10 11">
<text>a triacylglycerol + H2O = a diacylglycerol + a fatty acid + H(+)</text>
<dbReference type="Rhea" id="RHEA:12044"/>
<dbReference type="ChEBI" id="CHEBI:15377"/>
<dbReference type="ChEBI" id="CHEBI:15378"/>
<dbReference type="ChEBI" id="CHEBI:17855"/>
<dbReference type="ChEBI" id="CHEBI:18035"/>
<dbReference type="ChEBI" id="CHEBI:28868"/>
<dbReference type="EC" id="3.1.1.3"/>
</reaction>
<physiologicalReaction direction="left-to-right" evidence="26">
<dbReference type="Rhea" id="RHEA:12045"/>
</physiologicalReaction>
</comment>
<comment type="catalytic activity">
<reaction evidence="10">
<text>1,2,3-tri-(9Z-octadecenoyl)-glycerol + H2O = (9Z)-octadecenoate + di-(9Z)-octadecenoylglycerol + H(+)</text>
<dbReference type="Rhea" id="RHEA:38575"/>
<dbReference type="ChEBI" id="CHEBI:15377"/>
<dbReference type="ChEBI" id="CHEBI:15378"/>
<dbReference type="ChEBI" id="CHEBI:30823"/>
<dbReference type="ChEBI" id="CHEBI:53753"/>
<dbReference type="ChEBI" id="CHEBI:75945"/>
</reaction>
<physiologicalReaction direction="left-to-right" evidence="28">
<dbReference type="Rhea" id="RHEA:38576"/>
</physiologicalReaction>
</comment>
<comment type="catalytic activity">
<reaction evidence="8">
<text>1,3-di-(9Z-octadecenoyl)-glycerol + 1-(9Z-octadecenoyl)-glycerol = 1,2,3-tri-(9Z-octadecenoyl)-glycerol + glycerol</text>
<dbReference type="Rhea" id="RHEA:38331"/>
<dbReference type="ChEBI" id="CHEBI:17754"/>
<dbReference type="ChEBI" id="CHEBI:53753"/>
<dbReference type="ChEBI" id="CHEBI:75342"/>
<dbReference type="ChEBI" id="CHEBI:75735"/>
</reaction>
<physiologicalReaction direction="left-to-right" evidence="27">
<dbReference type="Rhea" id="RHEA:38332"/>
</physiologicalReaction>
</comment>
<comment type="catalytic activity">
<reaction evidence="8">
<text>1,2-di-(9Z-octadecenoyl)-glycerol + 1-(9Z-octadecenoyl)-glycerol = 1,2,3-tri-(9Z-octadecenoyl)-glycerol + glycerol</text>
<dbReference type="Rhea" id="RHEA:38327"/>
<dbReference type="ChEBI" id="CHEBI:17754"/>
<dbReference type="ChEBI" id="CHEBI:52323"/>
<dbReference type="ChEBI" id="CHEBI:53753"/>
<dbReference type="ChEBI" id="CHEBI:75342"/>
</reaction>
<physiologicalReaction direction="left-to-right" evidence="27">
<dbReference type="Rhea" id="RHEA:38328"/>
</physiologicalReaction>
</comment>
<comment type="catalytic activity">
<reaction evidence="8">
<text>2 1-(9Z-octadecenoyl)-glycerol = 1,2-di-(9Z-octadecenoyl)-glycerol + glycerol</text>
<dbReference type="Rhea" id="RHEA:38323"/>
<dbReference type="ChEBI" id="CHEBI:17754"/>
<dbReference type="ChEBI" id="CHEBI:52323"/>
<dbReference type="ChEBI" id="CHEBI:75342"/>
</reaction>
<physiologicalReaction direction="left-to-right" evidence="27">
<dbReference type="Rhea" id="RHEA:38324"/>
</physiologicalReaction>
</comment>
<comment type="catalytic activity">
<reaction evidence="18">
<text>1,2,3-tri-(9Z-octadecenoyl)-glycerol + H2O = (9Z)-octadecenoate + 1,3-di-(9Z-octadecenoyl)-glycerol + H(+)</text>
<dbReference type="Rhea" id="RHEA:38387"/>
<dbReference type="ChEBI" id="CHEBI:15377"/>
<dbReference type="ChEBI" id="CHEBI:15378"/>
<dbReference type="ChEBI" id="CHEBI:30823"/>
<dbReference type="ChEBI" id="CHEBI:53753"/>
<dbReference type="ChEBI" id="CHEBI:75735"/>
</reaction>
<physiologicalReaction direction="left-to-right" evidence="29">
<dbReference type="Rhea" id="RHEA:38388"/>
</physiologicalReaction>
</comment>
<comment type="catalytic activity">
<reaction evidence="18">
<text>(9Z)-octadecenoate + 1,2-di-(9Z-octadecenoyl)-glycerol + H(+) = 1,2,3-tri-(9Z-octadecenoyl)-glycerol + H2O</text>
<dbReference type="Rhea" id="RHEA:38379"/>
<dbReference type="ChEBI" id="CHEBI:15377"/>
<dbReference type="ChEBI" id="CHEBI:15378"/>
<dbReference type="ChEBI" id="CHEBI:30823"/>
<dbReference type="ChEBI" id="CHEBI:52323"/>
<dbReference type="ChEBI" id="CHEBI:53753"/>
</reaction>
<physiologicalReaction direction="right-to-left" evidence="29">
<dbReference type="Rhea" id="RHEA:38381"/>
</physiologicalReaction>
</comment>
<comment type="catalytic activity">
<reaction evidence="18">
<text>1,2,3-tri-(9Z-octadecenoyl)-glycerol + all-trans-retinol = all-trans-retinyl 9Z-octadecenoate + di-(9Z)-octadecenoylglycerol</text>
<dbReference type="Rhea" id="RHEA:39987"/>
<dbReference type="ChEBI" id="CHEBI:17336"/>
<dbReference type="ChEBI" id="CHEBI:53753"/>
<dbReference type="ChEBI" id="CHEBI:70760"/>
<dbReference type="ChEBI" id="CHEBI:75945"/>
</reaction>
<physiologicalReaction direction="left-to-right" evidence="29">
<dbReference type="Rhea" id="RHEA:39988"/>
</physiologicalReaction>
</comment>
<comment type="catalytic activity">
<reaction evidence="5">
<text>1,2,3-tri-(9Z-octadecenoyl)-glycerol + H2O = (9Z)-octadecenoate + 2,3-di-(9Z)-octadecenoyl-sn-glycerol + H(+)</text>
<dbReference type="Rhea" id="RHEA:38391"/>
<dbReference type="ChEBI" id="CHEBI:15377"/>
<dbReference type="ChEBI" id="CHEBI:15378"/>
<dbReference type="ChEBI" id="CHEBI:30823"/>
<dbReference type="ChEBI" id="CHEBI:53753"/>
<dbReference type="ChEBI" id="CHEBI:75824"/>
</reaction>
<physiologicalReaction direction="left-to-right" evidence="5">
<dbReference type="Rhea" id="RHEA:38392"/>
</physiologicalReaction>
</comment>
<comment type="catalytic activity">
<reaction evidence="5">
<text>1,2,3-tri-(9Z)-hexadecenoylglycerol + H2O = (9Z)-hexadecenoate + 1,3-di-(9Z)-hexadecenoylglycerol + H(+)</text>
<dbReference type="Rhea" id="RHEA:38395"/>
<dbReference type="ChEBI" id="CHEBI:15377"/>
<dbReference type="ChEBI" id="CHEBI:15378"/>
<dbReference type="ChEBI" id="CHEBI:32372"/>
<dbReference type="ChEBI" id="CHEBI:75841"/>
<dbReference type="ChEBI" id="CHEBI:75849"/>
</reaction>
<physiologicalReaction direction="left-to-right" evidence="5">
<dbReference type="Rhea" id="RHEA:38396"/>
</physiologicalReaction>
</comment>
<comment type="catalytic activity">
<reaction evidence="5">
<text>1,2,3-tri-(9Z)-hexadecenoylglycerol + H2O = (9Z)-hexadecenoate + 2,3-di-(9Z)-hexadecenoyl-sn-glycerol + H(+)</text>
<dbReference type="Rhea" id="RHEA:38399"/>
<dbReference type="ChEBI" id="CHEBI:15377"/>
<dbReference type="ChEBI" id="CHEBI:15378"/>
<dbReference type="ChEBI" id="CHEBI:32372"/>
<dbReference type="ChEBI" id="CHEBI:75841"/>
<dbReference type="ChEBI" id="CHEBI:75853"/>
</reaction>
<physiologicalReaction direction="left-to-right" evidence="5">
<dbReference type="Rhea" id="RHEA:38400"/>
</physiologicalReaction>
</comment>
<comment type="catalytic activity">
<reaction evidence="5">
<text>1,2,3-tri-(9Z,12Z)-octadecadienoylglycerol + H2O = (9Z,12Z)-octadecadienoate + 1,3-di-(9Z,12Z)-octadecadienoylglycerol + H(+)</text>
<dbReference type="Rhea" id="RHEA:38403"/>
<dbReference type="ChEBI" id="CHEBI:15377"/>
<dbReference type="ChEBI" id="CHEBI:15378"/>
<dbReference type="ChEBI" id="CHEBI:30245"/>
<dbReference type="ChEBI" id="CHEBI:75844"/>
<dbReference type="ChEBI" id="CHEBI:75850"/>
</reaction>
<physiologicalReaction direction="left-to-right" evidence="5">
<dbReference type="Rhea" id="RHEA:38404"/>
</physiologicalReaction>
</comment>
<comment type="catalytic activity">
<reaction evidence="5">
<text>1,2,3-tri-(9Z,12Z)-octadecadienoylglycerol + H2O = (9Z,12Z)-octadecadienoate + 2,3-di-(9Z,12Z)-octadecadienoyl-sn-glycerol + H(+)</text>
<dbReference type="Rhea" id="RHEA:38407"/>
<dbReference type="ChEBI" id="CHEBI:15377"/>
<dbReference type="ChEBI" id="CHEBI:15378"/>
<dbReference type="ChEBI" id="CHEBI:30245"/>
<dbReference type="ChEBI" id="CHEBI:75844"/>
<dbReference type="ChEBI" id="CHEBI:75854"/>
</reaction>
<physiologicalReaction direction="left-to-right" evidence="5">
<dbReference type="Rhea" id="RHEA:38408"/>
</physiologicalReaction>
</comment>
<comment type="catalytic activity">
<reaction evidence="5">
<text>1,2,3-tri-(9Z,12Z,15Z)-octadecatrienoylglycerol + H2O = (9Z,12Z,15Z)-octadecatrienoate + 1,3-di-(9Z,12Z,15Z)-octadecatrienoylglycerol + H(+)</text>
<dbReference type="Rhea" id="RHEA:38411"/>
<dbReference type="ChEBI" id="CHEBI:15377"/>
<dbReference type="ChEBI" id="CHEBI:15378"/>
<dbReference type="ChEBI" id="CHEBI:32387"/>
<dbReference type="ChEBI" id="CHEBI:75845"/>
<dbReference type="ChEBI" id="CHEBI:75852"/>
</reaction>
<physiologicalReaction direction="left-to-right" evidence="5">
<dbReference type="Rhea" id="RHEA:38412"/>
</physiologicalReaction>
</comment>
<comment type="catalytic activity">
<reaction evidence="5">
<text>1,2,3-tri-(9Z,12Z,15Z)-octadecatrienoylglycerol + H2O = (9Z,12Z,15Z)-octadecatrienoate + 2,3-di-(9Z,12Z,15Z)-octadecatrienoyl-sn-glycerol + H(+)</text>
<dbReference type="Rhea" id="RHEA:38415"/>
<dbReference type="ChEBI" id="CHEBI:15377"/>
<dbReference type="ChEBI" id="CHEBI:15378"/>
<dbReference type="ChEBI" id="CHEBI:32387"/>
<dbReference type="ChEBI" id="CHEBI:75845"/>
<dbReference type="ChEBI" id="CHEBI:75855"/>
</reaction>
<physiologicalReaction direction="left-to-right" evidence="5">
<dbReference type="Rhea" id="RHEA:38416"/>
</physiologicalReaction>
</comment>
<comment type="catalytic activity">
<reaction evidence="5">
<text>1,3-di-(9Z)-octadecenoyl-2-hexadecanoylglycerol + H2O = 1,3-di-(9Z-octadecenoyl)-glycerol + H(+) + hexadecanoate</text>
<dbReference type="Rhea" id="RHEA:38419"/>
<dbReference type="ChEBI" id="CHEBI:7896"/>
<dbReference type="ChEBI" id="CHEBI:15377"/>
<dbReference type="ChEBI" id="CHEBI:15378"/>
<dbReference type="ChEBI" id="CHEBI:75735"/>
<dbReference type="ChEBI" id="CHEBI:75846"/>
</reaction>
<physiologicalReaction direction="left-to-right" evidence="5">
<dbReference type="Rhea" id="RHEA:38420"/>
</physiologicalReaction>
</comment>
<comment type="catalytic activity">
<reaction evidence="5">
<text>1,3-di-(9Z)-octadecenoyl-2-hexadecanoylglycerol + H2O = (9Z)-octadecenoate + 2-hexadecanoyl-3-(9Z)-octadecenoyl-sn-glycerol + H(+)</text>
<dbReference type="Rhea" id="RHEA:38431"/>
<dbReference type="ChEBI" id="CHEBI:15377"/>
<dbReference type="ChEBI" id="CHEBI:15378"/>
<dbReference type="ChEBI" id="CHEBI:30823"/>
<dbReference type="ChEBI" id="CHEBI:75846"/>
<dbReference type="ChEBI" id="CHEBI:75870"/>
</reaction>
<physiologicalReaction direction="left-to-right" evidence="5">
<dbReference type="Rhea" id="RHEA:38432"/>
</physiologicalReaction>
</comment>
<comment type="catalytic activity">
<reaction evidence="5">
<text>1,2-di-(9Z)-octadecenoyl-3-hexadecanoyl-sn-glycerol + H2O = (9Z)-octadecenoate + 1-(9Z)-octadecenoyl-3-hexadecanoyl-sn-glycerol + H(+)</text>
<dbReference type="Rhea" id="RHEA:38423"/>
<dbReference type="ChEBI" id="CHEBI:15377"/>
<dbReference type="ChEBI" id="CHEBI:15378"/>
<dbReference type="ChEBI" id="CHEBI:30823"/>
<dbReference type="ChEBI" id="CHEBI:75583"/>
<dbReference type="ChEBI" id="CHEBI:75867"/>
</reaction>
<physiologicalReaction direction="left-to-right" evidence="5">
<dbReference type="Rhea" id="RHEA:38424"/>
</physiologicalReaction>
</comment>
<comment type="catalytic activity">
<reaction evidence="5">
<text>1-hexadecanoyl-2,3-di-(9Z)-octadecenoyl-sn-glycerol + H2O = 2,3-di-(9Z)-octadecenoyl-sn-glycerol + H(+) + hexadecanoate</text>
<dbReference type="Rhea" id="RHEA:38427"/>
<dbReference type="ChEBI" id="CHEBI:7896"/>
<dbReference type="ChEBI" id="CHEBI:15377"/>
<dbReference type="ChEBI" id="CHEBI:15378"/>
<dbReference type="ChEBI" id="CHEBI:75824"/>
<dbReference type="ChEBI" id="CHEBI:75847"/>
</reaction>
<physiologicalReaction direction="left-to-right" evidence="5">
<dbReference type="Rhea" id="RHEA:38428"/>
</physiologicalReaction>
</comment>
<comment type="catalytic activity">
<reaction evidence="5">
<text>1-hexadecanoyl-2,3-di-(9Z)-octadecenoyl-sn-glycerol + H2O = (9Z)-octadecenoate + 1-hexadecanoyl-3-(9Z)-octadecenoyl-sn-glycerol + H(+)</text>
<dbReference type="Rhea" id="RHEA:38647"/>
<dbReference type="ChEBI" id="CHEBI:15377"/>
<dbReference type="ChEBI" id="CHEBI:15378"/>
<dbReference type="ChEBI" id="CHEBI:30823"/>
<dbReference type="ChEBI" id="CHEBI:75847"/>
<dbReference type="ChEBI" id="CHEBI:75868"/>
</reaction>
<physiologicalReaction direction="left-to-right" evidence="5">
<dbReference type="Rhea" id="RHEA:38648"/>
</physiologicalReaction>
</comment>
<comment type="catalytic activity">
<reaction evidence="5">
<text>1,2-di-(9Z)-octadecenoyl-3-hexadecanoyl-sn-glycerol + H2O = (9Z)-octadecenoate + 2-(9Z-octadecenoyl)-3-hexadecanoyl-sn-glycerol + H(+)</text>
<dbReference type="Rhea" id="RHEA:38643"/>
<dbReference type="ChEBI" id="CHEBI:15377"/>
<dbReference type="ChEBI" id="CHEBI:15378"/>
<dbReference type="ChEBI" id="CHEBI:30823"/>
<dbReference type="ChEBI" id="CHEBI:75546"/>
<dbReference type="ChEBI" id="CHEBI:75583"/>
</reaction>
<physiologicalReaction direction="left-to-right" evidence="5">
<dbReference type="Rhea" id="RHEA:38644"/>
</physiologicalReaction>
</comment>
<comment type="activity regulation">
<text evidence="8 16">Inhibited by BEL ((E)-6-(bromomethylene)-3-(1-naphthalenyl)-2H-tetrahydropyran-2-one), a suicide substrate inhibitor. No differences in enzymatic activity that uses (1,2-dilinoleoyl)-phosphatidylcholine as substrate was detected in the presence or absence of ATP. Activated by ABHD5 and SERPINF1.</text>
</comment>
<comment type="biophysicochemical properties">
<phDependence>
<text evidence="16">Optimum pH is 7.5 with (1,2-dilinoleoyl)-phosphatidylcholine as substrate.</text>
</phDependence>
</comment>
<comment type="pathway">
<text>Glycerolipid metabolism; triacylglycerol degradation.</text>
</comment>
<comment type="subunit">
<text evidence="5 16 20">Interacts with ABHD5; this association stimulates PNPLA2 triglyceride hydrolase activity (By similarity). Interacts with SERPINF1; interacts at one site of interaction (PubMed:17032652). Despite a colocalization in lipid droplets, it probably does not interact with PLIN (By similarity). Interacts with PLIN5; prevents interaction with ABHD5 (By similarity). Interacts with FAF2 (PubMed:23297223).</text>
</comment>
<comment type="subcellular location">
<subcellularLocation>
<location>Lipid droplet</location>
</subcellularLocation>
<subcellularLocation>
<location>Cell membrane</location>
<topology>Single-pass type II membrane protein</topology>
</subcellularLocation>
</comment>
<comment type="alternative products">
<event type="alternative splicing"/>
<isoform>
<id>Q96AD5-1</id>
<name>1</name>
<sequence type="displayed"/>
</isoform>
<isoform>
<id>Q96AD5-2</id>
<name>2</name>
<sequence type="described" ref="VSP_026421"/>
</isoform>
</comment>
<comment type="tissue specificity">
<text evidence="10 11 13 16">Highest expression in adipose tissue. Also detected in heart, skeletal muscle, and portions of the gastrointestinal tract. Detected in normal retina and retinoblastoma cells. Detected in retinal pigment epithelium and, at lower intensity, in the inner segments of photoreceptors and in the ganglion cell layer of the neural retina (at protein level).</text>
</comment>
<comment type="developmental stage">
<text evidence="13 15 16">Induced during differentiation of primary preadipocytes to adipocytes. Expression increased from fetal to adult in retinal pigment epithelium.</text>
</comment>
<comment type="PTM">
<text evidence="4 19">Phosphorylation at Ser-404 by PKA is increased during fasting and moderate intensity exercise, and moderately increases lipolytic activity (By similarity). Phosphorylation at Ser-404 is increased upon beta-adrenergic stimulation.</text>
</comment>
<comment type="polymorphism">
<text evidence="14">Genetic variations in PNPLA2 may influence plasma free fatty acids and triglycerides levels, and fasting glucose concentrations.</text>
</comment>
<comment type="disease">
<text evidence="14">Genetic variations in PNPLA2 may be associated with risk of diabetes mellitus type 2.</text>
</comment>
<comment type="disease" evidence="17">
<disease id="DI-02050">
<name>Neutral lipid storage disease with myopathy</name>
<acronym>NLSDM</acronym>
<description>Neutral lipid storage disorder (NLSD) with myopathy but without ichthyosis. NLSDs are characterized by the presence of triglyceride-containing cytoplasmic droplets in leukocytes and in other tissues, including bone marrow, skin, and muscle. Individuals with NLSDM did not show obesity, in spite of a defect in triglyceride degradation in fibroblasts and in marked triglyceride storage in liver, muscles, and other visceral cells.</description>
<dbReference type="MIM" id="610717"/>
</disease>
<text>The disease is caused by mutations affecting the gene represented in this entry.</text>
</comment>
<comment type="sequence caution" evidence="26">
<conflict type="frameshift">
<sequence resource="EMBL-CDS" id="AAP34448" version="1"/>
</conflict>
</comment>
<comment type="sequence caution" evidence="26">
<conflict type="erroneous initiation">
<sequence resource="EMBL-CDS" id="CAC01131" version="1"/>
</conflict>
<text>Extended N-terminus.</text>
</comment>
<comment type="sequence caution" evidence="26">
<conflict type="erroneous initiation">
<sequence resource="EMBL-CDS" id="CAC01132" version="1"/>
</conflict>
<text>Extended N-terminus.</text>
</comment>
<dbReference type="EC" id="3.1.1.3" evidence="10"/>
<dbReference type="EMBL" id="AY894804">
<property type="protein sequence ID" value="AAW81962.1"/>
<property type="molecule type" value="mRNA"/>
</dbReference>
<dbReference type="EMBL" id="AJ278475">
<property type="protein sequence ID" value="CAC01131.1"/>
<property type="status" value="ALT_INIT"/>
<property type="molecule type" value="mRNA"/>
</dbReference>
<dbReference type="EMBL" id="AJ278476">
<property type="protein sequence ID" value="CAC01132.1"/>
<property type="status" value="ALT_INIT"/>
<property type="molecule type" value="mRNA"/>
</dbReference>
<dbReference type="EMBL" id="AY203925">
<property type="protein sequence ID" value="AAP34448.1"/>
<property type="status" value="ALT_FRAME"/>
<property type="molecule type" value="mRNA"/>
</dbReference>
<dbReference type="EMBL" id="BC011958">
<property type="protein sequence ID" value="AAH11958.1"/>
<property type="molecule type" value="mRNA"/>
</dbReference>
<dbReference type="EMBL" id="BC017280">
<property type="protein sequence ID" value="AAH17280.1"/>
<property type="molecule type" value="mRNA"/>
</dbReference>
<dbReference type="EMBL" id="AF055000">
<property type="protein sequence ID" value="AAC09354.1"/>
<property type="molecule type" value="mRNA"/>
</dbReference>
<dbReference type="CCDS" id="CCDS7718.1">
<molecule id="Q96AD5-1"/>
</dbReference>
<dbReference type="RefSeq" id="NP_065109.1">
<molecule id="Q96AD5-1"/>
<property type="nucleotide sequence ID" value="NM_020376.3"/>
</dbReference>
<dbReference type="RefSeq" id="XP_016873517.1">
<molecule id="Q96AD5-1"/>
<property type="nucleotide sequence ID" value="XM_017018028.1"/>
</dbReference>
<dbReference type="BioGRID" id="121370">
<property type="interactions" value="19"/>
</dbReference>
<dbReference type="IntAct" id="Q96AD5">
<property type="interactions" value="12"/>
</dbReference>
<dbReference type="MINT" id="Q96AD5"/>
<dbReference type="STRING" id="9606.ENSP00000337701"/>
<dbReference type="BindingDB" id="Q96AD5"/>
<dbReference type="ChEMBL" id="CHEMBL3822353"/>
<dbReference type="SwissLipids" id="SLP:000000311"/>
<dbReference type="GlyGen" id="Q96AD5">
<property type="glycosylation" value="1 site"/>
</dbReference>
<dbReference type="iPTMnet" id="Q96AD5"/>
<dbReference type="PhosphoSitePlus" id="Q96AD5"/>
<dbReference type="BioMuta" id="PNPLA2"/>
<dbReference type="DMDM" id="74731110"/>
<dbReference type="EPD" id="Q96AD5"/>
<dbReference type="jPOST" id="Q96AD5"/>
<dbReference type="MassIVE" id="Q96AD5"/>
<dbReference type="MaxQB" id="Q96AD5"/>
<dbReference type="PaxDb" id="Q96AD5"/>
<dbReference type="PeptideAtlas" id="Q96AD5"/>
<dbReference type="PRIDE" id="Q96AD5"/>
<dbReference type="ProteomicsDB" id="75955">
<molecule id="Q96AD5-1"/>
</dbReference>
<dbReference type="ProteomicsDB" id="75956">
<molecule id="Q96AD5-2"/>
</dbReference>
<dbReference type="Antibodypedia" id="22689">
<property type="antibodies" value="512 antibodies"/>
</dbReference>
<dbReference type="DNASU" id="57104"/>
<dbReference type="Ensembl" id="ENST00000336615">
<molecule id="Q96AD5-1"/>
<property type="protein sequence ID" value="ENSP00000337701"/>
<property type="gene ID" value="ENSG00000177666"/>
</dbReference>
<dbReference type="GeneID" id="57104"/>
<dbReference type="KEGG" id="hsa:57104"/>
<dbReference type="UCSC" id="uc001lrt.4">
<molecule id="Q96AD5-1"/>
<property type="organism name" value="human"/>
</dbReference>
<dbReference type="CTD" id="57104"/>
<dbReference type="DisGeNET" id="57104"/>
<dbReference type="EuPathDB" id="HostDB:ENSG00000177666.15"/>
<dbReference type="GeneCards" id="PNPLA2"/>
<dbReference type="HGNC" id="HGNC:30802">
<property type="gene designation" value="PNPLA2"/>
</dbReference>
<dbReference type="HPA" id="ENSG00000177666">
<property type="expression patterns" value="Group enriched (adipose tissue, breast)"/>
</dbReference>
<dbReference type="MalaCards" id="PNPLA2"/>
<dbReference type="MIM" id="609059">
<property type="type" value="gene"/>
</dbReference>
<dbReference type="MIM" id="610717">
<property type="type" value="phenotype"/>
</dbReference>
<dbReference type="neXtProt" id="NX_Q96AD5"/>
<dbReference type="OpenTargets" id="ENSG00000177666"/>
<dbReference type="Orphanet" id="98908">
<property type="disease" value="Neutral lipid storage myopathy"/>
</dbReference>
<dbReference type="Orphanet" id="565612">
<property type="disease" value="Triglyceride deposit cardiomyovasculopathy"/>
</dbReference>
<dbReference type="PharmGKB" id="PA134903083"/>
<dbReference type="eggNOG" id="KOG3773">
<property type="taxonomic scope" value="Eukaryota"/>
</dbReference>
<dbReference type="GeneTree" id="ENSGT00940000160155"/>
<dbReference type="HOGENOM" id="CLU_018371_0_1_1"/>
<dbReference type="InParanoid" id="Q96AD5"/>
<dbReference type="KO" id="K16816"/>
<dbReference type="OMA" id="RDMCKQG"/>
<dbReference type="OrthoDB" id="1204225at2759"/>
<dbReference type="PhylomeDB" id="Q96AD5"/>
<dbReference type="TreeFam" id="TF314272"/>
<dbReference type="PathwayCommons" id="Q96AD5"/>
<dbReference type="Reactome" id="R-HSA-1482883">
<property type="pathway name" value="Acyl chain remodeling of DAG and TAG"/>
</dbReference>
<dbReference type="Reactome" id="R-HSA-381426">
<property type="pathway name" value="Regulation of Insulin-like Growth Factor (IGF) transport and uptake by Insulin-like Growth Factor Binding Proteins (IGFBPs)"/>
</dbReference>
<dbReference type="Reactome" id="R-HSA-8957275">
<property type="pathway name" value="Post-translational protein phosphorylation"/>
</dbReference>
<dbReference type="UniPathway" id="UPA00256"/>
<dbReference type="BioGRID-ORCS" id="57104">
<property type="hits" value="5 hits in 871 CRISPR screens"/>
</dbReference>
<dbReference type="ChiTaRS" id="PNPLA2">
<property type="organism name" value="human"/>
</dbReference>
<dbReference type="GeneWiki" id="PNPLA2"/>
<dbReference type="GenomeRNAi" id="57104"/>
<dbReference type="Pharos" id="Q96AD5">
<property type="development level" value="Tchem"/>
</dbReference>
<dbReference type="PRO" id="PR:Q96AD5"/>
<dbReference type="Proteomes" id="UP000005640">
<property type="component" value="Chromosome 11"/>
</dbReference>
<dbReference type="RNAct" id="Q96AD5">
<property type="molecule type" value="protein"/>
</dbReference>
<dbReference type="Bgee" id="ENSG00000177666">
<property type="expression patterns" value="Expressed in subcutaneous adipose tissue and 226 other tissues"/>
</dbReference>
<dbReference type="Genevisible" id="Q96AD5">
<property type="organism ID" value="HS"/>
</dbReference>
<dbReference type="GO" id="GO:0005737">
<property type="term" value="C:cytoplasm"/>
<property type="evidence" value="ECO:0000318"/>
<property type="project" value="GO_Central"/>
</dbReference>
<dbReference type="GO" id="GO:0005829">
<property type="term" value="C:cytosol"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="Ensembl"/>
</dbReference>
<dbReference type="GO" id="GO:0005788">
<property type="term" value="C:endoplasmic reticulum lumen"/>
<property type="evidence" value="ECO:0000304"/>
<property type="project" value="Reactome"/>
</dbReference>
<dbReference type="GO" id="GO:0005789">
<property type="term" value="C:endoplasmic reticulum membrane"/>
<property type="evidence" value="ECO:0000304"/>
<property type="project" value="Reactome"/>
</dbReference>
<dbReference type="GO" id="GO:0016021">
<property type="term" value="C:integral component of membrane"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="UniProtKB-KW"/>
</dbReference>
<dbReference type="GO" id="GO:0005811">
<property type="term" value="C:lipid droplet"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0016020">
<property type="term" value="C:membrane"/>
<property type="evidence" value="ECO:0000318"/>
<property type="project" value="GO_Central"/>
</dbReference>
<dbReference type="GO" id="GO:0005654">
<property type="term" value="C:nucleoplasm"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="HPA"/>
</dbReference>
<dbReference type="GO" id="GO:0005886">
<property type="term" value="C:plasma membrane"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="UniProtKB-SubCell"/>
</dbReference>
<dbReference type="GO" id="GO:0050253">
<property type="term" value="F:retinyl-palmitate esterase activity"/>
<property type="evidence" value="ECO:0000269"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0004806">
<property type="term" value="F:triglyceride lipase activity"/>
<property type="evidence" value="ECO:0000269"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0036155">
<property type="term" value="P:acylglycerol acyl-chain remodeling"/>
<property type="evidence" value="ECO:0000304"/>
<property type="project" value="Reactome"/>
</dbReference>
<dbReference type="GO" id="GO:0044267">
<property type="term" value="P:cellular protein metabolic process"/>
<property type="evidence" value="ECO:0000304"/>
<property type="project" value="Reactome"/>
</dbReference>
<dbReference type="GO" id="GO:0006651">
<property type="term" value="P:diacylglycerol biosynthetic process"/>
<property type="evidence" value="ECO:0000250"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0034389">
<property type="term" value="P:lipid droplet organization"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="Ensembl"/>
</dbReference>
<dbReference type="GO" id="GO:0055088">
<property type="term" value="P:lipid homeostasis"/>
<property type="evidence" value="ECO:0000318"/>
<property type="project" value="GO_Central"/>
</dbReference>
<dbReference type="GO" id="GO:0019915">
<property type="term" value="P:lipid storage"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="Ensembl"/>
</dbReference>
<dbReference type="GO" id="GO:0010891">
<property type="term" value="P:negative regulation of sequestering of triglyceride"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0010898">
<property type="term" value="P:positive regulation of triglyceride catabolic process"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0043687">
<property type="term" value="P:post-translational protein modification"/>
<property type="evidence" value="ECO:0000304"/>
<property type="project" value="Reactome"/>
</dbReference>
<dbReference type="GO" id="GO:0019433">
<property type="term" value="P:triglyceride catabolic process"/>
<property type="evidence" value="ECO:0000250"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="CDD" id="cd07220">
<property type="entry name" value="Pat_PNPLA2"/>
<property type="match status" value="1"/>
</dbReference>
<dbReference type="InterPro" id="IPR016035">
<property type="entry name" value="Acyl_Trfase/lysoPLipase"/>
</dbReference>
<dbReference type="InterPro" id="IPR033562">
<property type="entry name" value="PLPL"/>
</dbReference>
<dbReference type="InterPro" id="IPR033903">
<property type="entry name" value="PNPLA2"/>
</dbReference>
<dbReference type="InterPro" id="IPR002641">
<property type="entry name" value="PNPLA_dom"/>
</dbReference>
<dbReference type="PANTHER" id="PTHR12406">
<property type="entry name" value="PTHR12406"/>
<property type="match status" value="1"/>
</dbReference>
<dbReference type="Pfam" id="PF01734">
<property type="entry name" value="Patatin"/>
<property type="match status" value="1"/>
</dbReference>
<dbReference type="SUPFAM" id="SSF52151">
<property type="entry name" value="SSF52151"/>
<property type="match status" value="1"/>
</dbReference>
<dbReference type="PROSITE" id="PS51635">
<property type="entry name" value="PNPLA"/>
<property type="match status" value="1"/>
</dbReference>
<proteinExistence type="evidence at protein level"/>
<keyword id="KW-0025">Alternative splicing</keyword>
<keyword id="KW-1003">Cell membrane</keyword>
<keyword id="KW-0225">Disease mutation</keyword>
<keyword id="KW-0325">Glycoprotein</keyword>
<keyword id="KW-0378">Hydrolase</keyword>
<keyword id="KW-0442">Lipid degradation</keyword>
<keyword id="KW-0551">Lipid droplet</keyword>
<keyword id="KW-0443">Lipid metabolism</keyword>
<keyword id="KW-0472">Membrane</keyword>
<keyword id="KW-0597">Phosphoprotein</keyword>
<keyword id="KW-0621">Polymorphism</keyword>
<keyword id="KW-1185">Reference proteome</keyword>
<keyword id="KW-0735">Signal-anchor</keyword>
<keyword id="KW-0812">Transmembrane</keyword>
<keyword id="KW-1133">Transmembrane helix</keyword>
<feature type="chain" description="Patatin-like phospholipase domain-containing protein 2" id="PRO_0000292527">
<location>
<begin position="1"/>
<end position="504"/>
</location>
</feature>
<feature type="topological domain" description="Cytoplasmic" evidence="6">
<location>
<begin position="1"/>
<end position="8"/>
</location>
</feature>
<feature type="transmembrane region" description="Helical; Signal-anchor for type II membrane protein" evidence="6">
<location>
<begin position="9"/>
<end position="29"/>
</location>
</feature>
<feature type="topological domain" description="Lumenal" evidence="6">
<location>
<begin position="30"/>
<end position="504"/>
</location>
</feature>
<feature type="domain" description="PNPLA" evidence="7">
<location>
<begin position="10"/>
<end position="179"/>
</location>
</feature>
<feature type="short sequence motif" description="GXGXXG" evidence="7">
<location>
<begin position="14"/>
<end position="19"/>
</location>
</feature>
<feature type="short sequence motif" description="GXSXG" evidence="7">
<location>
<begin position="45"/>
<end position="49"/>
</location>
</feature>
<feature type="short sequence motif" description="DGA/G" evidence="7">
<location>
<begin position="166"/>
<end position="168"/>
</location>
</feature>
<feature type="active site" description="Nucleophile" evidence="7">
<location>
<position position="47"/>
</location>
</feature>
<feature type="active site" description="Proton acceptor" evidence="7">
<location>
<position position="166"/>
</location>
</feature>
<feature type="modified residue" description="Phosphoserine; in vitro" evidence="5">
<location>
<position position="372"/>
</location>
</feature>
<feature type="modified residue" description="Phosphoserine; by PKA and FAM20C" evidence="2 19 21">
<location>
<position position="404"/>
</location>
</feature>
<feature type="modified residue" description="Phosphoserine" evidence="1 2 3">
<location>
<position position="428"/>
</location>
</feature>
<feature type="glycosylation site" description="N-linked (GlcNAc...) asparagine" evidence="6">
<location>
<position position="39"/>
</location>
</feature>
<feature type="splice variant" description="In isoform 2." id="VSP_026421" evidence="23">
<location>
<begin position="1"/>
<end position="324"/>
</location>
</feature>
<feature type="sequence variant" description="In NLSDM; dbSNP:rs121918259." id="VAR_032995" evidence="17">
<original>P</original>
<variation>L</variation>
<location>
<position position="195"/>
</location>
</feature>
<feature type="sequence variant" description="In dbSNP:rs140612115." id="VAR_032996" evidence="14">
<original>L</original>
<variation>F</variation>
<location>
<position position="219"/>
</location>
</feature>
<feature type="sequence variant" description="In dbSNP:rs140201358." id="VAR_032997" evidence="14">
<original>N</original>
<variation>K</variation>
<location>
<position position="252"/>
</location>
</feature>
<feature type="sequence variant" description="In dbSNP:rs1138693." id="VAR_032998" evidence="9 14 22">
<original>L</original>
<variation>P</variation>
<location>
<position position="481"/>
</location>
</feature>
<feature type="mutagenesis site" description="Reduces rate of lipid hydrolysis; does not affect the localization around the rim of the adiposomes." evidence="11 12">
<original>S</original>
<variation>A</variation>
<location>
<position position="47"/>
</location>
</feature>
<feature type="sequence conflict" description="In Ref. 5; AAC09354." ref="5" evidence="26">
<original>R</original>
<variation>G</variation>
<location>
<position position="163"/>
</location>
</feature>
<feature type="sequence conflict" description="In Ref. 1; AAW81962." ref="1" evidence="26">
<original>I</original>
<variation>V</variation>
<location>
<position position="296"/>
</location>
</feature>
<feature type="sequence conflict" description="In Ref. 3; AAP34448." ref="3" evidence="26">
<original>A</original>
<variation>G</variation>
<location>
<position position="333"/>
</location>
</feature>
<feature type="sequence conflict" description="In Ref. 1; AAW81962." ref="1" evidence="26">
<original>R</original>
<variation>C</variation>
<location>
<position position="351"/>
</location>
</feature>
<feature type="sequence conflict" description="In Ref. 2; CAC01131/CAC01132." ref="2" evidence="26">
<original>V</original>
<variation>L</variation>
<location>
<position position="402"/>
</location>
</feature>
<feature type="sequence conflict" description="In Ref. 1; AAW81962." ref="1" evidence="26">
<original>L</original>
<variation>P</variation>
<location>
<position position="419"/>
</location>
</feature>
<evidence key="1" type="ECO:0000244">
<source>
<dbReference type="PubMed" id="21406692"/>
</source>
</evidence>
<evidence key="2" type="ECO:0000244">
<source>
<dbReference type="PubMed" id="23186163"/>
</source>
</evidence>
<evidence key="3" type="ECO:0000244">
<source>
<dbReference type="PubMed" id="24275569"/>
</source>
</evidence>
<evidence key="4" type="ECO:0000250"/>
<evidence key="5" type="ECO:0000250">
<source>
<dbReference type="UniProtKB" id="Q8BJ56"/>
</source>
</evidence>
<evidence key="6" type="ECO:0000255"/>
<evidence key="7" type="ECO:0000255">
<source>
<dbReference type="PROSITE-ProRule" id="PRU01161"/>
</source>
</evidence>
<evidence key="8" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="15364929"/>
</source>
</evidence>
<evidence key="9" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="15489334"/>
</source>
</evidence>
<evidence key="10" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="15550674"/>
</source>
</evidence>
<evidence key="11" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="16150821"/>
</source>
</evidence>
<evidence key="12" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="16239926"/>
</source>
</evidence>
<evidence key="13" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="16249444"/>
</source>
</evidence>
<evidence key="14" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="16644682"/>
</source>
</evidence>
<evidence key="15" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="16705060"/>
</source>
</evidence>
<evidence key="16" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="17032652"/>
</source>
</evidence>
<evidence key="17" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="17187067"/>
</source>
</evidence>
<evidence key="18" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="17603008"/>
</source>
</evidence>
<evidence key="19" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="22733971"/>
</source>
</evidence>
<evidence key="20" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="23297223"/>
</source>
</evidence>
<evidence key="21" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="26091039"/>
</source>
</evidence>
<evidence key="22" type="ECO:0000269">
<source ref="2"/>
</evidence>
<evidence key="23" type="ECO:0000303">
<source>
<dbReference type="PubMed" id="15498874"/>
</source>
</evidence>
<evidence key="24" type="ECO:0000303">
<source>
<dbReference type="PubMed" id="15550674"/>
</source>
</evidence>
<evidence key="25" type="ECO:0000303">
<source>
<dbReference type="PubMed" id="17603008"/>
</source>
</evidence>
<evidence key="26" type="ECO:0000305"/>
<evidence key="27" type="ECO:0000305">
<source>
<dbReference type="PubMed" id="15364929"/>
</source>
</evidence>
<evidence key="28" type="ECO:0000305">
<source>
<dbReference type="PubMed" id="15550674"/>
</source>
</evidence>
<evidence key="29" type="ECO:0000305">
<source>
<dbReference type="PubMed" id="17603008"/>
</source>
</evidence>
<evidence key="30" type="ECO:0000312">
<source>
<dbReference type="HGNC" id="HGNC:30802"/>
</source>
</evidence>
<sequence length="504" mass="55316" checksum="D9C16F942AB0B3C7" modified="2001-12-01" version="1">MFPREKTWNISFAGCGFLGVYYVGVASCLREHAPFLVANATHIYGASAGALTATALVTGVCLGEAGAKFIEVSKEARKRFLGPLHPSFNLVKIIRSFLLKVLPADSHEHASGRLGISLTRVSDGENVIISHFNSKDELIQANVCSGFIPVYCGLIPPSLQGVRYVDGGISDNLPLYELKNTITVSPFSGESDICPQDSSTNIHELRVTNTSIQFNLRNLYRLSKALFPPEPLVLREMCKQGYRDGLRFLQRNGLLNRPNPLLALPPARPHGPEDKDQAVESAQAEDYSQLPGEDHILEHLPARLNEALLEACVEPTDLLTTLSNMLPVRLATAMMVPYTLPLESALSFTIRLLEWLPDVPEDIRWMKEQTGSICQYLVMRAKRKLGRHLPSRLPEQVELRRVQSLPSVPLSCAAYREALPGWMRNNLSLGDALAKWEECQRQLLLGLFCTNVAFPPEALRMRAPADPAPAPADPASPQHQLAGPAPLLSTPAPEARPVIGALGL</sequence>
</entry>
<copyright>
Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
Distributed under the Creative Commons Attribution (CC BY 4.0) License
</copyright>
</uniprot>

